TARIS Biomedical is building a world-class specialty pharmaceutical company focused on providing powerful new treatments to the millions of patients suffering from bladder diseases. We are advancing therapies for debilitating conditions, including bladder cancer and overactive bladder, enabled by continuous local dosing where it is needed.
View Top Employees from TARIS BioWebsite | http://www.tarisbio.com |
Revenue | $12 million |
Funding | $85.9 million |
Employees | 25 (10 on RocketReach) |
Founded | 2008 |
Phone | (781) 676-7750 |
Fax | (781) 676-7788 |
Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
Industry | Pharmaceuticals, Manufacturing General, Urology, Manufacturing, Continuous Local Dosing, Bladder Diseases, Oncology, Voiding Dysfunction |
Web Rank | 15 Million |
Keywords | Taris Biomedical, Taris Biomedical Actavis 2019 |
Competitors | Cytochroma Inc., PolyPid Ltd., Presidio Pharmaceuticals, Inc., QRxPharma, UroGen Pharma (formerly TheraCoat) |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 541711 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular TARIS Bio employee's phone or email?
The TARIS Bio annual revenue was $12 million in 2024.
Ari Axelrod is the Interim Chief Executive Officer of TARIS Bio.
10 people are employed at TARIS Bio.
TARIS Bio is based in Arlington, Massachusetts.
The NAICS codes for TARIS Bio are [541711, 54171, 54, 5417, 541].
The SIC codes for TARIS Bio are [283, 28].